Report overview
Paronychia usually happens when the skin around an individual's nail is irritated or harmed. Paronychia is a soft tissue infection of the skin around the fingernails and toenails. Bacteria which cause this type of infection are known as Candida. The infection begins as cellulitis but may progress to a definite abscess.
This report contains market size and forecasts of Paronychia Drugs in Global, including the following market information:
Global Paronychia Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Paronychia Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Mupirocin Ointment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Paronychia Drugs include GlaxoSmithKline, Teva Pharmaceutical, Eli Lilly, Fougera Pharmaceuticals, Taro Pharmaceutical Industries, Glenmark Generics and Jonakayem Pharma Formulation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Paronychia Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Paronychia Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Paronychia Drugs Market Segment Percentages, by Type, 2021 (%)
Mupirocin Ointment
Fusidic Acid Ointment
Gentamicin Ointment
Dicloxacillin
Others
Global Paronychia Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Paronychia Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Dermatology Center
Others
Global Paronychia Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Paronychia Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Paronychia Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Paronychia Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Teva Pharmaceutical
Eli Lilly
Fougera Pharmaceuticals
Taro Pharmaceutical Industries
Glenmark Generics
Jonakayem Pharma Formulation
